RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,807,000 | -0.8% | 662,056 | +20.4% | 0.02% | 0.0% |
| Q1 2017 | $1,821,000 | +97.3% | 550,000 | +41.9% | 0.02% | +100.0% |
| Q4 2016 | $923,000 | -68.8% | 387,697 | -51.8% | 0.01% | -62.5% |
| Q3 2016 | $2,954,000 | +32.5% | 805,000 | -19.5% | 0.03% | +39.1% |
| Q2 2016 | $2,229,000 | +7.2% | 999,700 | 0.0% | 0.02% | +53.3% |
| Q1 2016 | $2,079,000 | +29.8% | 999,700 | +89.1% | 0.02% | +50.0% |
| Q4 2015 | $1,602,000 | – | 528,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,550,000 | $14,606,000 | 4.17% |
| Sio Capital Management, LLC | 1,843,501 | $5,918,000 | 2.03% |
| Sofinnova Investments, Inc. | 3,260,931 | $10,467,000 | 0.93% |
| Boxer Capital, LLC | 2,321,900 | $7,453,000 | 0.83% |
| Rhenman & Partners Asset Management AB | 2,113,988 | $6,786,000 | 0.68% |
| Palo Alto Investors LP | 3,966,087 | $12,731,000 | 0.52% |
| Rock Springs Capital Management LP | 4,125,000 | $13,241,000 | 0.48% |
| NEA Management Company, LLC | 3,243,150 | $10,411,000 | 0.45% |
| B. Riley Financial, Inc. | 473,343 | $1,519,000 | 0.43% |
| Walleye Capital LLC | 151,923 | $488,000 | 0.23% |